SINGAPORE, Oct 21, 2024 – ACROMETA Group Limited, also known as ACROMETA, together with its subsidiaries collectively referred to as the “Group”, made a significant announcement today regarding its strategic business decisions. The company has officially entered into a sale and purchase agreement (SPA) for the disposal of all shares it holds in Life Science Incubator Holdings Pte Ltd.

This pivotal move is part of ACROMETA’s broader strategy to streamline its operations and focus on its core business activities. The disposal of the shares is anticipated to have a substantial impact on the company’s portfolio, allowing it to allocate resources more efficiently and enhance shareholder value in the long-term.

The sale and purchase agreement marks a turning point for ACROMETA, as it seeks to optimize its business operations and reinforce its market position in its primary sectors. This strategic divestment is aligned with ACROMETA’s long-term goals of operational excellence and leadership in its industry.